Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(hexadecyloxy)-6-methyl-4h-3,1-benzoxazin-4-one
2. Atl-962
1. 282526-98-1
2. Citilistat
3. Atl-962
4. 2-(hexadecyloxy)-6-methyl-4h-3,1-benzoxazin-4-one
5. Atl 962
6. 2-hexadecoxy-6-methyl-3,1-benzoxazin-4-one
7. 4h-3,1-benzoxazin-4-one, 2-(hexadecyloxy)-6-methyl-
8. 2-hexadecyloxy-6-methyl-4h-3,1-benzoxazin-4-one
9. Lc5g1jua39
10. 2-(hexadecyloxy)-6-methyl-4h-benzo[d][1,3]oxazin-4-one
11. Cetilistat [inn]
12. Oblean
13. Cametor
14. Unii-lc5g1jua39
15. Cetilistat (jan/usan/inn)
16. Atl962
17. Cetilistat [usan:inn:ban:jan]
18. Oblean (tn)
19. Cetilistat [mi]
20. Cetilistat [jan]
21. Cetilistat [usan]
22. Cetilistat [who-dd]
23. Schembl367612
24. Chembl2103825
25. Gtpl11433
26. Dtxsid90182506
27. Ex-a983
28. Chebi:134721
29. Hms3873m13
30. Act02675
31. Amy25231
32. Bcp07371
33. Ac-219
34. Mfcd09839697
35. S4930
36. Zinc14128264
37. Akos015915375
38. Ccg-268665
39. Cs-5623
40. Db06586
41. Ks-1251
42. Sb17399
43. Atl-962;atl962;atl 962
44. Ncgc00408859-01
45. Bc166233
46. Hy-14471
47. Ft-0657021
48. D09208
49. F16711
50. 526c981
51. A819389
52. Q3010545
| Molecular Weight | 401.6 g/mol |
|---|---|
| Molecular Formula | C25H39NO3 |
| XLogP3 | 9.8 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 16 |
| Exact Mass | 401.29299411 g/mol |
| Monoisotopic Mass | 401.29299411 g/mol |
| Topological Polar Surface Area | 47.9 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 477 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in obesity.
Anti-Obesity Agents
Agents that increase energy expenditure and weight loss by neural and metabolic regulation. (See all compounds classified as Anti-Obesity Agents.)
Enzyme Inhibitors
Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)
Lipid Regulating Agents
Substances that alter the metabolism of LIPIDS. (See all compounds classified as Lipid Regulating Agents.)
Cetilistat is a gastrointestinal lipase inhibitor that blocks fat digestion and absorption, leading to reduced energy intake, and thus weight loss. It is distinct from most other anti-obesity agents as it does not act on the brain to reduce appetite, but acts peripherally. The compound remains in the gastrointestinal tract with no significant absorption into the body.
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Market Place
ABOUT THIS PAGE
A Cetilistat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cetilistat, including repackagers and relabelers. The FDA regulates Cetilistat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cetilistat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cetilistat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cetilistat supplier is an individual or a company that provides Cetilistat active pharmaceutical ingredient (API) or Cetilistat finished formulations upon request. The Cetilistat suppliers may include Cetilistat API manufacturers, exporters, distributors and traders.
click here to find a list of Cetilistat suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Cetilistat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cetilistat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cetilistat GMP manufacturer or Cetilistat GMP API supplier for your needs.
A Cetilistat CoA (Certificate of Analysis) is a formal document that attests to Cetilistat's compliance with Cetilistat specifications and serves as a tool for batch-level quality control.
Cetilistat CoA mostly includes findings from lab analyses of a specific batch. For each Cetilistat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cetilistat may be tested according to a variety of international standards, such as European Pharmacopoeia (Cetilistat EP), Cetilistat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cetilistat USP).
LOOKING FOR A SUPPLIER?
